Just for completeness: CBI became the regulator in Dec 2020 due to Brexit. Increased communications from the regulator as they sought to become familiar with EML is no surprise. At some point the CBI came to a conclusion regarding EML's AML/CTF adherence and raised such concerns with the company, inviting it to reply. No reason to think the timelines provided by EML are wrong.
EML's response to ASX queries is detailed, specifically who knew what and when.
The CEO had shares sold by UBS under a structured finance facility arrangement that was set up so he could fund taking up his rights in Dec 2019. UBS exercised its right under the facility to sell the shares to extinguish the liability to UBS.
To insinuate that something else happened here, without evidence is dangerous.
@retiredyoung what ensuing court case? And no - without any evidence of wrong doing - no reason for EML to be suspended at this time.
ISX Price at posting:
$1.07 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
